SUCCESSFUL TREATMENT OF THE COMPLICATED FORM OF NON-HODGKIN'S LYMPHOMA OF THE CECUM. CASE REPORT


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Non-Hodgkin’s lymphomas (NHL) as oncopathology have long been known to oncologists. Good results have been achieved in the complicated course of NHL of the digestive tracT., but a lethal outcome is still often recorded because NHL of the digestive tract is diagnosed almost at the stage of development of complications. Description of the clinical case. A clinical case of NHL in a patient of 34 years is presented. Based on clinical, instrumental, laboratory, intraoperative and morphological datA., the diagnosis of «non-Hodgkin’s lymphoma of the cecum» was determined. Complications: hollow viscus perforation, diffuse fecal purulent peritonitis. Despite the presence of such a terrible, up to a fatal complication, as hollow viscus perforation with secondary diffuse fecal purulent peritonitis in the patienT., the life-saving medicinal treatment according to the R CHOP-21 scheme was carried out. After four courses of the 1st-line chemotherapy with complete regression of the tumor process, patient with the formed enteric fistula was hospitalized in the surgical thoracoabdominal unit where an combined-expanded right-sided hemicolectomy with extensive enterectomy with the formation of an end-to-side ileotransversostomy was performed. Currently, the patient is alive, and signs of recurrence and disease progression were not recorded during follow-up examination. Conclusion. The described clinical case proves that treatment of a complicated course of NHL of the digestive tract is not futile; complication is not a sign of neglect of the oncological process.

Full Text

Restricted Access

About the authors

G. A Khakimovl

Tashkent Pediatric Medical Institute

Email: hgg_doc@mail.ru
clinical resident Tashkent, Uzbekistan

Kh. I Dzhumaniezov

Tashkent Pediatric Medical Institute

Tashkent, Uzbekistan

Sh. Sh Kadyrov

Tashkent Pediatric Medical Institute

Tashkent, Uzbekistan

Sh. V Ziyaev

Tashkent Pediatric Medical Institute

Tashkent, Uzbekistan

G. G Khakimova

N.N. Blokhin RCRC

Moscow, Russia

References

  1. Богданов А.Н., Максимов А.Г, Саржевский В.О., Аносов Н.А. Особые формы неходжкинских лим-фом. Практическая онкология. 2004;5(3):217-2.
  2. Грачева А.В. Роль лучевой терапии в комбинированном лечении больных экстранодальными неходжкинскими лимфомами. Дисс. канд. мед. наук. СПб., 2013. 25 с.
  3. Ильин Н.В., Виноградова Ю.Н., Николаева Е.Н., и др. Роль лучевой терапии в комбинированном лечении больных экстранодальными неходжкинскими лимфомами (НХЛ). Материалы Невского радиологического форума 2009. Под ред. В.И. Амосова. СПб., 2009. 225 с.
  4. Ильин Н.В., Виноградова Ю.Н., Николаева Е.Н. и др. Первичные экстранодальные лимфомы. В кн. Лимфомы. Научно-практическое издание / Под ред. А.М. Гранова., Н.В. Ильина. СПб., 2010. С. 171-215.
  5. Клиническая онкогематология: Руководство для врачей / Под ред. М.А. Волковой. М., 2001. C. 364-65.
  6. Кокосадзе Н.В. MALT-лимфома желудка: морфоиммунологические основы диагноза на материале гастробиопсии. Дисс. канд. мед. наук. М., 2005. 25 с.
  7. Колесник Е.А. Злокачественные лимфомы пищеварительного тракта. Онкология. 2003;5(1):63- 8
  8. Крицкая А.В., Виноградова Ю.Н., Ходжибекова М.М. и др. Лучевое лечение в комбинированной терапии неходжкинских лим-фом желудка. Клиническая онкогематология. 2012;5(3):214-17.
  9. Мазуров В.И., Криволапов Ю.А. Классификация лимфом. Морфология, иммунофенотип, молекулярная генетика неходжкинсуих лимфом. Практическая онкология. 2004;5(3):171-76.
  10. Малихова О.А. Современная стратегия комплексной эндоскопической диагностики и мониторинг неходжкинских лимфом желудка. Дисс. докт. мед. наук. М., 2010. 194 с.
  11. Неред С.Н., Шаленков В.А., Стилиди И.С., Поддубная И.В. Хирургическое и консервативное лечение осложненных форм неходжкинских лимфом желудка. Онкология. 2012;1:28-32.
  12. Поддубная И.В., Неред С.Н., Суанова З.А., Шаленков В.А. Неходжкинские лимфомы кишечника - первичное экстранодальное поражение. Современная онкология. 2010;3:80-4.
  13. Шаленков В.А. Хирургическое лечение осложненных форм лимфом желудочно-кишечного тракта. Дисс. канд. мед. наук. М., 2012.
  14. Al-Akwaa A.M., Siddiqui N., Al-Mofleh i.A. Primary gastric lymphoma. World J. Gastroenterol. 2004;10:5-11.
  15. Aleman B.M., Haas R.L., Van der Maazen R.W. The role of radiation therapy in the treatment of lymphoma of the gastrointestinal tract. Best Pract. Res. Clin. Gastroenterol. 2010; 24(1):27-34.
  16. Amer M.H., El-akkad S. Gastrointestinal lymphomas in adults. Clinical features and management of 300 cases. Gastroenterol. 1994;106:846-58.
  17. Ansell S.M., Armitage J. Non-Hodgkin lymphoma: diagnosis and treatment. Mayo Clin. Proc. 2005;80:1087-97.
  18. Aviles A., Diaz-Maqueo J.C., de la Torre A., et al. is surgery necessary in the treatment of primary gastric non-Hodgkin's lymphoma? Leuk. Lymphoma. 1991;5:365-69.
  19. Aviles A., Nambo M.J., Neri N., et al. The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Ann. Surg. 2004; 240(1):44-50.
  20. Bartlett D.L., Karpeh M.S., Filippa D.A., Brennan M.F. Long-Term Follow-Up After Curative Surgery for Early Gastric Lymphoma. Ann. Surg. 1996; 223(1):53-62.
  21. Bellesi G., Alterini A., Messori A., et al. Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas. Br. J. Cancer. 1989;60:244-48.
  22. Binn M., Ruskone-Fourmestraux A., Lepage E., et al. Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann. Oncol. 2003;14:1751-57.
  23. Brands F., Mo'nig S.Р., Raab M. Treatment and prognosis of gastric lymphoma. Eur. J. Surg. 1997;163:803-13.
  24. Buneton J.N., Manzino J.J., Caramella E. Gastrointestinal lymphomas. in: Bruneton J.N., Schieder M. (eds) Radiology of lymphomas. Springer: Berlin, Heidelberg, New York, 1986. P. 70-89.
  25. Burgers J.M., Taal B.G., van Heerde Р., et al. Treatment results of primary stage i and ii non-Hodgkin's lymphoma of the stomach. Radiother. Oncol. 1988;11:319-26.
  26. Chan J.K.C. Tumors of the lymphoreticular system, including spleen and thymus. Diagnostic histopathology of tumors. Fletcher C.D. (ed.). New York: Churchill Livingstone, 2000;2:1099-317.
  27. Cogliatti S.B., Schmid U., Schumacher U., et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterol. 1991;101(5):1159-70.
  28. Dabbs D.J. Diagnostic immunohistochemistry. New York: Churchill Livingstone. 2002. 673 р.
  29. Damaj G., Verkarre V, Delmer A., et al. Primary follicular lymphoma of the gastrointestinal tract: a study 25 cases and a literature review. Ann. Oncol. 2003;14(4):623-29.
  30. Dawson i.M., Cornes J.S., Morson B.C. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br. J. Surg. 1961; 49:80-9.
  31. Della Biancia C., Hunt M., Furhang E., et al. Radiation treatment planning techniques for lymphoma of the stomach. int. J. Radiat. Oncol. Biol. Phys. 2005;62(3):745-51.
  32. Eidt S., Stolte M., Fisher R. Helicobacter pilori gastritis and primary gastric non-Hodgkin's lymphomas. J. Clin. Pathol. 1994;47:436-39.
  33. Engels E.A. infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev. 2007;16:401-4.
  34. Selgukbiricik F., Tural D., Elicin O., et al. Primary Gastric Lymphoma: Conservative Treatment Modality. is Not inferior to Surgery for Early-Stage Disease. iSRN Oncology. 2012;2012(Article iD951816):6. doi: 10.5402/2012/951816.
  35. Feller A.C., Diebold J., Lennert K. Histopathology of nodal and extranodal non,Hodgkin's lymphomas (based on the WHO classification). 3rd ed. Berlin. New York: Springer, 2004. 428 р.
  36. Ferreri A.J., Cordio S., Ponzoni M., Villa E. Non-surgical treatment with primary chemotherapy, with or without radiation therapy, of stage i-ii highgrade gastric lymphoma. Leuk. Lymphoma. 1999;
  37. Ferrucci P.F., Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br. J. Haematol. 2007; 136:521-38.
  38. Fleming D., Mitchell S., Dilawari R.A. The role of surgery in the management of gastric lymphoma. Cancer. 1982;49(6):1135-41.
  39. Freeman C., Berg J.W., Cutler S.J. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252-60.
  40. Ghai S., Pattison J., Ghai S., et al. Primary gastrointestinal lymphoma: spectrum of imaging findings with pathologic correlation. Radiographics. 2007;27:1371-88.
  41. Papaxoinis G., Papageorgiou S., Rontogianni D. Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk. Lymphoma. 2006;47:2140-46.
  42. Gobbi P.G., Dionigi Р., Barbieri F., et al. The role of surgery in the multimodal treatment of primary gastric non-Hodgkin's lymphomas. A report of 76 cases and review of the literature. Cancer. 1990;65(11):2528.
  43. Haim N., Leviov M., Ben-Arieh Y., et al. Intermediate and high-grade gastric non-Hodgkin's lymphoma: a prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy. Leuk. Lymphoma. 1995;17:321-26.
  44. Hampson F.A., Shaw A.S. Response assessment in lymphoma. Clin. Radiol. 2008;63:125-35.
  45. Harris N.L., Jaffe E.S., Diebold J., et al. World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-airlie house. VirginiA., November 1997. New York: Kluwer Academic/Plenum Publishers, J. Clin. Oncol. 2002;XVIII:355.
  46. Herrmann R., Panahon A.M., Barcos M.Р., et al. Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer. 1980;46:215-22.
  47. Ibrahim E.M., Ezzat A.A., Raja M.A., et al. Primary gastric non-Hodgkin's lymphoma: clinical features, managemenT., and prognosis of 185 patients with diffuse large B-cell lymphoma. Ann. Oncol. 1999;10:1441-49.
  48. Isaacson P. Gastric MALT lymphoma: from concept to cure. Ann. Oncol. 1999;10:637-45.
  49. Ishikura S., Tobinai K., Ohtsu A., et al. Japanese multicenter phase II study of CHOP followed by radiotherapy in stage I-II, diffuse large B-cell lymphoma of the stomach. Cancer Sci. 2005;96:349-52.
  50. Jaffe E.S., Harris N.L., Stein H., Vardiman J.W., eds. WHO Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001. 352 p.
  51. Kang Y.K., Chang H.M., Ryoo B.Y., et al. Comparison of surgery+chemotherapy±radiation with chemotherapy±radiation for localized aggressive B-cell primary gastric lymphomas. Seoul: The 28th Ann. Meet. Korean Cancer Associat. 2002; (Abstr. 129):127.
  52. Koch Р., Del Valle F., Berdel W.E., et al. Primary gastrointestinal non-Hodgkin's lymphoma: i. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the german multicenter study GIT NHL 01/92. J. Clin. Oncol. 2001;19(18):3861-73.
  53. Koch Р., del Valle F., Berdel W.E., et al. Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma-results of the prospective German Multicenter Study GIT NHL 01/92. J. Clin. Oncol. 2001;19:3874-83.
  54. Koch Р., Probst A., Berdel W.E., et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J. Clin. Oncol. 2005;23:7050-59.
  55. Koch Р., Eich H.T., Bargetzi M., et al. Extranodales Marginalzonen-Lymphom (MZoL) Stand: Oktober. 2012. 10178 Berlin. 57p.
  56. Lewin K.J., Ranchod M., Dorfman R.F. Lymphomas of the gastrointestinal tract. A study of 117 cases presenting with gastrointestinal disease. Cancer. 1978;42(2):693-707.
  57. Liu H.-T., Hsu C., Chen C.-L., et al. Chemotherapy alone versus, surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomach. Am. J. Hematol. 2000;64(3):175-79.
  58. Lupescu I.G., Grasu M., Goldis G., et al. Computer tomographic evaluation of digestive tract non-Hodgkin lymphomas. J. Gastrointestin. Liver Dis. 2007;16:315-19.
  59. Maisey N., Norman A., Prior Y., Cunningham D. Chemotherapy for primary gastric lymphoma: does in-patient observation prevent complications? Clin. Oncol. 2004;16(1):48-52.
  60. Maor M.H., Velasquez W.S., Fuller L.M., Silvermintz K.B. Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma. J. Clin. Oncol. 1990;8:266-71.
  61. Maor M.H., North L.B., Cabanillas F.F., et al. Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma. Int. J. Radiat. Oncol. Biol. Phys. 1998;41:647-50.
  62. Bautista-Quach M.A., Ake C.D., Chen M., Wang' J. Review Article. Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features. 2012;3(3).
  63. Mittal B., Wasserman T.H., Griffith R.C. Non-Hodgkin's lymphoma of the stomach. Am. J. Gastroenterol. 1983;78:780-87.
  64. Montalban C., Castrillo J.M., Abraira V, et al. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients. Ann. Oncol. 1995;6:355-62.
  65. Muller A.M., Ihorst G., Mertelsmann R., Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann. Hematol. 2005;84:1-12.
  66. Musshoff K. Clinical staging classification of non-Hodgkin's lymphomas (author's transl). Strahlentherapie. 1977;153:218-21.
  67. Nakamura S., Yao T., Aoyagi K., et al. Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer (Philad.). 1997;79:3-11.
  68. Narita M., Yatabe Y., Asai J., Mori N. Primary gastric lymphomas: morphologic, immunohistochemical and immunogenetic analyses. Pathol. Int. 1996;46:623-29.
  69. Papaxoinis G., Papageorgiou S., Rontogianni D., et al. Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk. Lymphoma. 2006;47(10): 2140-46.
  70. Pinotti G., Zucca E., Roggero E., et al. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk. Lymphoma. 1997;26(5-6):527-37.
  71. Ghimire Р., Wu G.-Y., Zhu L. Primary gastrointestinal lymphoma. World J. Gastroenterol. 2011;17(6):697-707.
  72. Psyrri A., Papageorgiou S., Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann. Oncol. 2008;19:1992-99.
  73. Puspok A., Raderer M., Chott A., et al. Endoscopic ultrasound in the follow up and response assessment of patients with primary gastric lymphoma. Gut. 2002;51:691-94.
  74. Radan L., Fischer D., Bar-Shalom R., et al. FDG avidity and PET/CT patterns in primary gastric lymphoma. Eur. J. Nucl. Med. Mol. Imaging. 2008;35:1424-30.
  75. Raderer M., Chott A., Drach J., et al. Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary? Ann. Oncol. 2002;13: 1094-98.
  76. Raderer M., de Boer J.P Role of chemotherapy in gastric MALT lymphom A., diffuse large B-cell lymphoma and other lymphomas. Best Pract. Res. Clin. Gastroenterol. 2010;24:19-26.
  77. Reinartz G., Willich N., Koch P. Strahlentherapie bei primaren gastrointestinalen Lymphomen. Chir. Gastroenterol. 2002;18:53-9.
  78. Reinartz G., Koch Р., Berdel W.E., Willich N. Radiotherapy in Primary Gastrointestinal Non-Hodgkin's Lymphoma. Dtsch. Arztebl. 2006;103(44):2940.
  79. Bautista-Quach M.A., Ake C.D., Chen M., Wang J. Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features. J. Gastrointest. Oncol. 2012;3(3):209-25. doi: 10.3978/j.issn.2078-6891.2012.024.
  80. Rizvi M.A., Evens A.M., Tallman M.S., et al. T-cell non-Hodgkin lymphoma. Blood. 2006;107: 1255-64.
  81. Rohatiner A., D' Amore F., Coiffier B., et al. Report on a workshop convened to discuss the pathological and staging classification of gastrointestinal tract lymphoma. Ann. Oncol. 1994;5(5): 397-400.
  82. Scholz F.J., Vincent M.E. The stomach. In: C.E. Putman, C.E. Ravin (eds). Textbook of diagnostic imaging. Saunders. PhiladelphiA., 1994. Р. 713-41.
  83. Schwarz R.J., Conners J.M., Schmidt N., et al. Diagnosis and management of stage IE and stage IIE gastric lymphomas. Am. J. Surg. 1993; 165:561-65.
  84. Sharma S., Singhal S., De S., et al. Primary gastric lymphoma: a prospective analysis of 12 cases and review of the literature. J. Surg. Oncol. 1990;43(4):231-38.
  85. Shiu M.H., Nisce L.Z., Pinna A., et al. Recent results of multimodal therapy of gastric lymphoma. Cancer. 1986;58:1389-99.
  86. Taal B.G., Burgers J.M. Primary non-Hodgkin's lymphoma of the stomach: endoscopic diagnosis and the role of surgery. Sc.and J. Gastroenterol. Suppl. 1991;188:33-7.
  87. Thieblemont C., Dumontet C., Bouafia F., et al. Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 19762001. Leuk. Lymphoma. 2003;44(2):257-62.
  88. Tondini C., Balzarotti M., Santoro A., et al. Initial chemotherapy for primary resectable largecell lymphoma of the stomach. Ann. Oncol. 1997;8:497-99.
  89. Torres W.E., Gedgaudas_McClees R.K. Lymphoma. In: Gore RM, Levine MS, Laufer I (eds) Textbook of gas_ trointestinal radiology. Saunders. PhiladelphiA., 1994. 2570 р.
  90. Wohrer S., Puspok A., Drach J., et al. Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma. Ann. Oncol. 2004;15:1086-90.
  91. Wotherspoon A.C., Ortiz-Hidalgo C., Falzon M.R., Isaacson PG. Helicobacter pilori_associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338:1175-76.
  92. Sbitti Y., Ismaili N., Bensouda Y., et al. Management of stage one and two-E gastric large B-cell lymphoma: chemotherapy alone or surgery followed by chemotherapy? J. Hematol. Oncol. 2010;3:23.
  93. Yoon S.S., Coit D.G., Portlock C.S., et al. The diminishing role of surgery in the treatment of gastric lymphoma. Ann. Surg. 2004;240:28-37.
  94. Mishima Y., Terui Y., Yokoyama M., et al. R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma. Exp. Hematol. Oncol. 2012;1:30. doi: 10.1186/2162-3619-1-30.
  95. Pinotti G., Zucca E., Roggero E., et al. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk. Lymphoma. 1997;26(5-6):527-37.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2018 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies